Target
TLR4
1 abstract
Abstract
OncoTherad immunotherapy plus platelet rich plasma as potential therapeutic strategy for ovarian cancer: The role of toll-like receptors 2 and 4 signaling pathways.Org: Laboratory of Urogenital Carcinogenesis and Immunotherapy (LCURGIM), Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil, Laboratory of Urogenital Carcinogenesis and Immunotherapy (LCURGIM) – Departament of Structural and Functional Biology, Institute of Biology - University of Cam, Campinas, Brazil, Laboratory of Urogenital Carcinogenesis and Immunotherapy (LCURGIM) - School of Medicine, University of Campinas (UNICAMP), Campinas, Brazil, Laboratory of urogenital carcinogenesis and immunotherapy (LCURGIM), Campinas, Brazil, Centro de Oncologia Integrativa e Prevenção - COIP, São Paulo, Brazil, Department of Pathology, School of Medicine, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil, Campinas, Brazil, University of Campinas (UNICAMP), Campinas, Brazil, Laboratory of Urogenital Carcinogenesis and Immunotherapy, School of Medicine, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil, Campinas, Brazil, Institute of Biology, University of Campinas (UNICAMP),